2-Amino-3,4-Dihydroquinazolines Exhibit Potent Antimalarial Activity by Targeting Plasmepsin X.

Saved in:
Bibliographic Details
Title: 2-Amino-3,4-Dihydroquinazolines Exhibit Potent Antimalarial Activity by Targeting Plasmepsin X.
Authors: Dans MG; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia., Awalt JK; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia., Nguyen N; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia., Palandri J; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia., Ngo A; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia., Jarman KE; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia., Jeon JH; Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York New York 10032, United States.; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York New York 10032, United States., Yeo T; Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York New York 10032, United States.; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York New York 10032, United States., Park H; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York New York 10032, United States.; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York New York 10032, United States., Uhlemann AC; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York New York 10032, United States.; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York New York 10032, United States., Mao EY; Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide 5005, Australia., Gancheva MR; Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide 5005, Australia., Wilson DW; Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide 5005, Australia., Mukherjee P; TCG Lifesciences, Kolkata, West Bengal 700091, India., Chakraborty A; TCG Lifesciences, Kolkata, West Bengal 700091, India., Kristan M; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K., Stewart L; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K., Sutherland CJ; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K., Baud D; MMV Medicines for Malaria Venture, Geneva 1215, Switzerland., Brand S; MMV Medicines for Malaria Venture, Geneva 1215, Switzerland., Fidock DA; Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York New York 10032, United States.; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York New York 10032, United States.; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York New York 10032, United States., Jackson PF; Emerging Science & Innovation, Discovery Sciences, Janssen R&D LLC, La Jolla, California 92121, United States., Cowman AF; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia., Sleebs BE; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia.
Source: ACS infectious diseases [ACS Infect Dis] 2026 Jul 09. Date of Electronic Publication: 2026 Jul 09.
Publication Type: Journal Article
Journal Info: Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2373-8227
DOI:10.1021/acsinfecdis.6c00258